MILAN & BERLIN--(BUSINESS WIRE)--WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the ...

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...

The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...

SCS is often used as a last resort for pain management for cancer patients who do not respond to any other forms of treatment, says Eellan Sivanesan, M.D., assistant professor of anesthesiology and ...

Abbott announced new five-year data demonstrating that its neuromodulation therapies, including its proprietary BurstDR spinal cord stimulation (SCS) waveform and dorsal root ganglion stimulation ...

We’ve long viewed neuromodulation as a field that offered great promise but faced meaningful challenges to realizing that potential. Thanks to a spurt in innovation in spinal cord stimulation--the ...

Boston Scientific has shared a range of data highlighting the benefits of spinal cord stimulation (SCS) therapies within its neuromodulation portfolio. The medtech giant presented a total of 17 ...

Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy. An analysis from Italy of 7 studies that investigated ...

Medtronic plc MDT announced a major regulatory advancement in the fast-growing neuromodulation space. Per the announcement, the company received revised commercial labeling approval from the FDA for ...

Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...